clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Studies Find Blood Proteins That May Predict Cancer Seven Years before…
News & Features
Google and Harvard Precisely Map Tiny Brain Sample
Molecular Dx
New Study Links Ribosomal DNA Copy Number with Disease Risk
Molecular Dx
Accounting for Biological Sex Improves Accuracy of Heart Failure Diagnosis
News & Features
Lupus Treatment Outcomes Affected by Combinations of Antiviral Proteins
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
FDA Puts Five Trials of Gilead Cancer Candidate Magrolimab on Partial Hold
Triple-negative breast cancer
News & Features
FDA Puts Five Trials of Gilead Cancer Candidate Magrolimab on Partial Hold
Alex Philippidis
-
January 26, 2022
0
News & Features
Triple Negative Breast Cancer’s Newest Target: MAPK4
Sophia Ktori
-
January 12, 2022
0
News & Features
Researchers ID Immunotherapy Target for Brain Metastases from Breast Cancer
Christina Jackson
-
September 22, 2021
0
News & Features
Genetic Alterations that Aid Resistance to Triple Negative Breast Cancer Drug Identified
John Sterling
-
August 18, 2021
0
News & Features
New Triple Negative Breast Cancer Therapy Developed
Anjali A. Sarkar, PhD
-
August 4, 2021
0
News & Features
Statins May Improve Outcomes in Triple-Negative Breast Cancer Patients
Malorye Branca
-
August 3, 2021
0
News & Features
Promising New Cancer Drug Target: RNA-Binding Proteins
Sophia Ktori
-
July 6, 2021
0
News & Features
Potential Treatment Option for Some Patients with Triple Negative Breast Cancer Discovered
Helen Albert
-
June 10, 2021
0
News & Features
New Evidence Prolactin is Possible Target for Breast Cancer Drugs
Malorye Branca
-
April 27, 2021
0
Molecular Dx
New RNA-seq Method Uses Aneuploidy to Distinguish Cancer Cells
Chris Anderson
-
January 19, 2021
0
1
2
3
4
Page 3 of 4
Related Content
Studies Find Blood Proteins That May Predict Cancer Seven Years before It Is Diagnosed
Seventeen More Genes Identified That Drive Age-Related Mutations in Blood Cells
Intense Ultrasound Releases Cancer Biomarkers, Allows for Earlier Cancer Detection
Personal Vaccine Combined with Immune-Boosting Agent Improves Treatment of Malignant Glioma
Inside Precision Medicine
